Navigation Links
Jiangbo Pharmaceuticals Reports Results for Third Quarter of Fiscal Year 2010
Date:5/17/2010

ion channels. We continue to evaluate strategic opportunities to cost-effectively market our key products to deliver organic revenue growth in future quarters."

Third Quarter Fiscal Year 2010 Results

Total revenue for the three months ended March 31, 2010 was $25.6 million, compared to $25.7 million for the three months ended March 31, 2009. Sales volume for Clarithromycin sustained-released tablets grew 23.0% year-over-year as a result of the Company's reinforced sales efforts and tighter management of its distribution channels. Similarly, sales volume for Radix Isatidis dispersible tablets rose 44.7% over the prior year quarter. Strong sales growth of these two products was offset by a decline in sales volume for Itopride Hydrochloride granules and Baobaole chewable tablets, which were down 10.8% and 35.9%, respectively. Itopride and Baobaole continued to experience competition from similar products, including some that are included in the National Basic Medical Insurance Catalog. As the sales growth of OTC drugs, such as Baobaole chewable tablets and Radix Isatidis dispersible tablets, require continued support through advertising and promotion, management is evaluating the appropriate investment in TV advertising to drive the sales.

Gross profit in the third quarter was $18.6 million, as compared to $18.6 million in the prior year period. Gross margin decreased to 72.7% from 73.4%, primarily due to changes in the sales of product mix.

Selling, general and administrative expenses were $3.8 million for the three months ended March 31, 2010, down 15.1% from $4.
'/>"/>

SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Jiangbo Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2010
2. Jiangbo Pharmaceuticals Announces Conference Call to Discuss Results for Its Second Quarter of Fiscal Year 2010
3. Jiangbo Pharmaceuticals Osteomyelitis Treatment Tablets to be Included in Chinas National Insurance Directory
4. Jiangbo Pharmaceuticals Obtains Renewal of GMP Certificate
5. Jiangbo Pharmaceuticals Announces First Quarter Fiscal Year 2010 Results
6. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for the First Quarter of Fiscal Year 2010
7. Lotus Pharmaceuticals, Inc. Reports Strong First Quarter 2010 Financial Results
8. DUSA Pharmaceuticals Announces Slate of Nominees for Election to the Board of Directors
9. Ferring Pharmaceuticals Announces Disco Icon Gloria Gaynor as National Spokesperson for EUFLEXXA(R)
10. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2010 First Quarter Earnings Conference Call on Monday, May 17, 2010 at 9:30 a.m. ET
11. Jazz Pharmaceuticals Announces Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014  Kindred Hospital Houston Northwest, ... the opening of its new outpatient wound healing ... to people with chronic, hard to heal wounds. ... lead to amputation, lower leg wounds related to ... closure, and traumatic injury wounds which are complex ...
(Date:7/11/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/tjlw9k/immunoprotein ... "Immunoprotein Diagnostic Testing Market - Forecasts to 2019: ... 6% and is expected to be valued at ... http://photos.prnewswire.com/prnh/20130307/600769 ... been segmented according to immunoprotein types which include ...
(Date:7/10/2014)... MUMBAI, India , July 11, 2014 /PRNewswire/ ... the treatment of cancer are being highlighted in ... Mumbai from 10-12 July, 2014.  Renowned ... meeting to share best practices and exchange knowledge ... more precise, accurate and efficient. ...
Breaking Medicine Technology:Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2Improving quality and access to advanced cancer care in India and South Asia 2Improving quality and access to advanced cancer care in India and South Asia 3Improving quality and access to advanced cancer care in India and South Asia 4Improving quality and access to advanced cancer care in India and South Asia 5
... used an electronic clinical system since its inception in 2009 ... technology with an enterprise clinical and financial solution from Prognosis ... out as a completely electronic hospital. But we realize that ... of our needs," says Jeremy Lyman, CFO at the 11-bed, ...
... IOD Incorporated™, a leading provider of integrated HIM ... announced its response to the Health and Human Services ... from October 1, 2013 to October 1, 2014. ... to HHS regulations published in 2009, the current ICD-9 ...
Cached Medicine Technology:Blue Mountain Hospital Selects Enterprise System from Prognosis HIS 2Blue Mountain Hospital Selects Enterprise System from Prognosis HIS 3IOD Incorporated Advises Healthcare Providers to Stay the Course in Preparation for ICD-10 2IOD Incorporated Advises Healthcare Providers to Stay the Course in Preparation for ICD-10 3
(Date:7/13/2014)... July 13, 2014 ECS ... commented, “As a parent of a special needs child, ... in the Seattle community for contemporary special education resources ... important alternative to students and families in the Seattle ... and environment for special education. We welcome the opportunity ...
(Date:7/13/2014)... If Dr. Lawrence Power has his way, ... at http://www.HealthYourself101.com will expand people’s understanding of the ... has set out to provide a health education platform on ... dare we say it? – entertaining to dig into and ... engage the remote learner – the solitary individual signing on ...
(Date:7/13/2014)... 13, 2014 According to the Living ... is a comprehensive guide that features a series of ... KP (keratosis pilaris). This guide consists of 14 ... Keratosis Pilaris? ,     Chapter 2: What Cause KP? ... I Have KP? ,     Chapter 4: Keratosis Pilaris ...
(Date:7/12/2014)... According to the new market research report "Security and ... Systems) - Global Forecasts and Analysis to 2014 - ... are estimated to be $6.08 billion in 2014 and ... reach $8.61 billion by 2020. , Browse more than ... 161 pages and in-depth TOC on "Security and Surveillance ...
(Date:7/12/2014)... one of the world’s leading wedding dress suppliers, has announced ... more, all these hot outfits are available at discounted prices, ... “We are proud to announce our new red evening dresses. ... In addition to the big discounts, low shipping costs also ... mean bad quality. All the red evening gowns are made ...
Breaking Medicine News(10 mins):Health News:New Private School, Emerald City School, Founded in Downtown Seattle Now Accepting 1st to 6th Grade Students Who Learn Differently 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 2Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 3Health News:Retired Ann Arbor Physician and Professor Wields New Media to Teach Health Science 4Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 2Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Security and Surveillance Radar Market Estimated to Reach $8.61 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Discounted Red Evening Gown Announced by iFitDress.com 2
... atrophy of their temporal lobe or damage to blood ... Alzheimers disease . ,Older adults showing signs ... Alzheimers than their peers. ,Alzheimers disease, a highly ... with other risk factors such as poor cognitive scores, ...
... the University of Southern California have identified a chemical ... brain to low blood sugar levels . ... to yield new insights in the fight against diabetes, ... the researchers, the chemical travels from the hindbrain, which ...
... Australian actress Toni Collette is expecting her first child with ... the news, and said that she and her hubby are ... happy. We are completely over the moon," News.com.au quoted the ... playing pregnant women in many of her films of late, ...
... ,Pull on rubber gloves. ,Smear Vaseline over your glasses , ,and there you have ... ... - Malcolm Cowley ,Hormone ... estrogen and often progesterone for post-menopausal women. ,The two ...
... Internet for conditions ranging from cold sores and shingles ... to prevent aging, enhance fertility, prevent cancer and get ... cadmium. , ,Selenium supplements have shown some ... activities, some scientists feel it might be effective against ...
... actor would never have slept with Marilyn Monroe, for she was ... that the two had a torrid sex romp on the set ... heart attack. ,However, author David Bret in his biography ... rumour was just not true. ,Bret writes that the ...
Cached Medicine News:Health News:Neurotransmitter That can Yield New Insights in the Fight Against Diabetes Identified 2Health News:Hormone Replacement Therapy Liberation at a Cost 2Health News:Hormone Replacement Therapy Liberation at a Cost 3Health News:Selenium Supplements Could Increase Diabetes Risk 2Health News:Selenium Supplements Could Increase Diabetes Risk 3
The TransNeb is a complete medication delivery system in a bag. The TransNeb is a compact, piston compressor providing high-performance while weighing only 11 oz. Versatility. Dependability. Simplici...
... A lightweight (4.2lbs) portable unit with a unique ... It features an oil free aluminum alloy integrated ... Available in a variety of combinations with ... Carrying bag is also available. , ...
The ACMI TurboFlow 18 L and 10 L Insufflators provide rapid distention for all laparoscopic procedures. Eleven built-in safety features make insufflation reliable and dependable....
... GenoID's kit is the first ... HPV for clinical diagnostic use. , ... high-risk and 5 low-risk genotypes of ... of PCR technology but simplifying the ...
Medicine Products: